PCSK9 Inhibitors Improve Survival in Some Cancer Patients on Immunotherapy
Researchers found a link between PCSK9 inhibitors and improved survival rates in certain cancer patients receiving immunotherapy. The study analyzed data from patients with various types of cancer.…